---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017946"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2023-05-17T23:59:59+00:00"
generated_at: "2026-06-14T22:43:54.008917+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Abeona shareholders elect directors, approve 2023 equity plan at annual meeting

## Summary
- Michael Amoroso (6.5M for) and Christine Silverstein (6.2M for) elected Class I directors until 2026.
- Abeona Therapeutics 2023 Equity Incentive Plan approved: 6.2M for, 569K against, 18K abstentions.
- Advisory vote on named executive officer compensation passed: 6.4M for, 282K against, 37K abstentions.
- Ratification of Whitley Penn LLP as independent auditor for FY2023 passed: 10.4M for, 49K against, 28K abstentions.

## SEC filing metadata
- accession: 0001493152-23-017946
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2023-05-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/0001493152-23-017946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017946
- JSON: https://secwatch.observer/filing/0001493152-23-017946.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017946.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.